The cost of prescription drugs remains a hot-button issue for consumers and policymakers. The vast majority of the public views drug prices as unreasonable, and one in four people taking prescription drugs report difficulty affording their medication. Recently, the Trump Administration, Congress and state and federal policy makers have focused renewed…
Featured Prescription Drugs Resources
This slideshow looks at past, present and future trends in prescription drug spending with a focus on the role of specialty drugs.
Slideshow See More
Related Prescription Drugs Resources
- Kaiser Health News Coverage of Prescription Drug Issues
- Snapshots of Recent State Initiatives in Medicaid Prescription Drug Cost Control
- Summary of Recent and Proposed Changes to Medicare Prescription Drug Coverage and Reimbursement
- Kaiser Health Tracking Poll – March 2018: Views on Prescription Drug Pricing and Medicare-for-all Proposals
- 10 Essential Facts About Medicare and Prescription Drug Spending
- No Limit: Medicare Part D Enrollees Exposed to High Out-of-Pocket Drug Costs Without a Hard Cap on Spending
- Public Opinion on the Use and Abuse of Prescription Opioids
- Searching for Savings in Medicare Drug Price Negotiations
- Prescription Drug Costs Break Through the Partisan Logjam
- Medicaid’s Most Costly Outpatient Drugs
- Retail Prescription Drugs Filled at Pharmacies (Annual per Capita)
- 2017 Employer Health Benefits Survey
This slideshow draws on recent Kaiser Family Foundation poll findings to provide an in-depth look at the public’s attitudes toward prescription drugs and their prices. Results include Americans’ opinions on drug affordability, pharmaceutical companies, and various potential measures that could lower prices.
Slideshow See More
- view as grid
- view as list
Analysis: Cost of Treating Opioid Addiction Rose Rapidly for Large Employers as the Number of Prescriptions Has Declined
A new Kaiser Family Foundation analysis finds that while the use of prescription opioids among people with employer-based health coverage has declined to its lowest levels in over a decade, the cost of treating addiction and overdoses has increased sharply. The annual cost of treating opioid addiction and overdose –…
This chart series highlights 5 key things to know about the intersection of the nation’s HIV and opioid epidemics.
Kaiser Health Tracking Poll – March 2018: Views on Prescription Drug Pricing and Medicare-for-all Proposals
More than a year into President Trump’s presidency, the March Kaiser Health Tracking Poll gauges the public’s top priorities for the president and Congress to do in the coming months. This month’s poll also measures perceptions on the cost of prescription drugs, attitudes towards policymakers’ actions to address drug prices, and views of pharmaceutical companies. In addition, with the 2018 midterm elections less than 8 months away, the KFF poll asks how important a national health plan is to voters.
Democrats Split on Whether to Fix the ACA or Push for a National Health Plan; Few Democratic Voters Say a National Health Plan is Their Top Issue for the Midterms As policymakers weigh strategies to address the high cost of prescription drugs, the latest Kaiser Health Tracking Poll finds that…
Rising Medicaid spending on prescription drugs has prompted many states to look for new ways to control such costs. Although drug spending increased more slowly in 2016 than in the previous two years, and although such expenditures constitute only six percent of all Medicaid spending (compared to 10% of national…
This issue brief provides a snapshot of current state initiatives aimed at addressing the cost of prescription drugs in Medicaid.
On February 9, 2018 the President signed into law the Bipartisan Budget Act of 2018, which included some provisions related to Medicare Part D prescription drug coverage. Shortly thereafter, the Office of Management and Budget released the President’s fiscal year (FY) 2019 budget, which also included several proposals related to Medicare Part D drug coverage and Part B drug reimbursement. This brief summarizes these recently enacted and proposed changes.